Clinical Trials
5 trialsNCT02506933 2026-05-11
Multi-antigen CMV-MVA Triplex Vaccine in Reducing CMV Complications in Patients Previously Infected With CMV and Undergoing Donor Hematopoietic Cell Transplant
City of Hope Medical Center
Phase 2 Active not recruiting
NCT02210078 2026-02-17
Donor Cytomegalovirus-Specific Cytotoxic T-Lymphocytes in Treating Patients With a Persistent Cytomegalovirus Infection
M.D. Anderson Cancer Center
Phase 2 Active not recruiting
NCT02396134 2025-03-03
Vaccine Therapy in Reducing the Frequency of Cytomegalovirus Events in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant
City of Hope Medical Center
Phase 2 Completed
NCT00285259 2024-10-21
Cytomegalovirus (CMV) Vaccine in Donors and Recipients Undergoing Allogeneic Hematopoietic Cell Transplant (HCT)
Astellas Pharma Inc
Phase 2 Completed
NCT03067155 2022-12-21
CMV Specific T Cell Therapy After Allogeneic Stem Cell Transplantation.
University Hospital, Ghent
Phase 2 Completed